Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01669200 · ClinicalTrials.gov registry record · NA

Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment

A NA study of Mild Cognitive Impairment, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
4
Enrollment target
1
Study location

NCT01669200 is a NA study of Mild Cognitive Impairment that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 4 participants, below the 1,271-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01669200, a NA study of Mild Cognitive Impairment, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this study is to assess whether daily dosing with medium chain triglycerides in subjects with mild cognitive impairment (MCI) will improve cognitive performance.

Conditions Studied

Interventions

  • OTHER Medium Chain Triglyceride Oil
  • OTHER Placebo Oil

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2012-08
Est. Completion 2014-10
Phase NA

What the Registry Record Tells You About NCT01669200

The ClinicalTrials.gov registry entry for NCT01669200 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,271-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (100% lower). The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Medium Chain Triglyceride Oil is the first listed.

NCT01669200 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT01669200 about?

NCT01669200 is a clinical study titled "Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment". The primary aim of this study is to assess whether daily dosing with medium chain triglycerides in subjects with mild cognitive impairment (MCI) will improve cognitive performance.

What is the current status of trial NCT01669200?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2012-08. Estimated completion is 2014-10.

What conditions does trial NCT01669200 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment.

What interventions are being tested in trial NCT01669200?

The interventions under investigation include: Medium Chain Triglyceride Oil (OTHER), Placebo Oil (OTHER).

Who is sponsoring clinical trial NCT01669200?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01669200 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.